Navigation Links
Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
Date:5/5/2008

Retrospective Chart Review in 10 Geographic Regions throughout the United States Presented at Pediatric Academic Societies (PAS) Annual Meeting

HONOLULU, May 5 /PRNewswire/ -- MedImmune announced today that the company presented results from a retrospective chart review that evaluated the use of Synagis(R) (palivizumab) as a preventive measure against respiratory syncytial virus (RSV) disease in high-risk infants. RSV is a leading cause of viral respiratory infection among preterm infants.

Approximately 4,000 medical records from premature infants born at 32-to-35 weeks gestational age were reviewed. Fifty percent of those infants received Synagis. RSV prophylaxis was requested, but not administered in about one quarter of these infants. This group was found to have an RSV hospitalization rate of 8.3 percent, which was almost three times the rate of RSV hospitalization among those infants whose physicians did not request RSV prophylaxis (2.9 percent).

"These data support our position that pediatricians should have the final say in the diagnosis and care of their high-risk patients," said Jessie Groothuis, M.D., lead author of the study and MedImmune vice president, medical and scientific affairs, infectious disease. "Our findings indicate that after nearly 10 years of use of Synagis, the clinical judgment and experience of physicians serve to identify infants at high risk of RSV hospitalization, and should be relied upon to ensure patients get proper care."

This retrospective chart review, conducted in 10 geographic regions across the United States, included 376 physicians from 2005 to 2006. Data were presented at a poster session at the Pediatric Academic Societies (PAS) Annual Meeting being held this week in Honolulu, HI.

About Synagis

Synagis (palivizumab) is indicated for the prevention of serious lung infections caused by respiratory syncytial virus (RSV) in children at high risk of RSV disease. Synagis is given
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
2. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
3. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
4. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
5. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
6. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
7. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
8. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
9. Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis
10. Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis
11. Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... NEW YORK, Nov. 25 Reportlinker.co...vailable in its catalogue: ,, Mammography Equ...://www.reportlinker.com/p0164330/Mammography-Equip...ing incidence of breast cancer in industrialized a... influencing growth in the mammography market. Glo...
(Date:11/25/2009)..., SAN DIEGO, Nov. 25 Nu...mpany focused on developing products for minimally...ounced today that it will host a conference call o...0 p.m. PT. The conference call will focus on curr...ny,s products and will include comments from manag...
(Date:11/25/2009)... DELFT, The Netherlands and JOHANNESBURG, Novembe...ice division and Pyxis Discovery announced today,t...jointly market both,companies, services. , ...lead discovery expertise,will be coupled with iThe...nthetic chemistry support to projects identified t...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Tubal Reversal Surgeons Reverse Adiana Sterilization 59262 1New strategy for mending broken hearts 3F 10316 1New strategy for mending broken hearts 3F 10316 2NHC Group CEO Paul Mirabelle Announces National Hearing Care 26apos 3Bs Proposal to Buy Bay Audiology Approved 59256 1
(Date:11/27/2009)...mission vehicles may reduce future disease burden,...althDay News) -- Encouraging city dwellers to walk...h greater public health benefits than increased us... found. , The study compared the projected heal...port scenarios for London, England, and Delhi, Ind...
(Date:11/27/2009)...i-purpose bilingual coloring books designed for ch...ess community to educate - inform parents and chil...sues to Dinosuars to ABC,S and a host of other top...RWEB) November 27, 2009 -- Today’s children ...hem busy any hour of the day, but one of the oldes...
(Date:11/26/2009)... Nov. 27 The diabetes population i...xt 25 years and annual medical spending on the dis...3 billion today, according to a study published in...nal Changing Diabetes ® Program (NCDP), a pr...y a team from the University of Chicago. ,, Acc...
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...on Communications announces a highly effective and...rs struggling to make an economic recovery. , ...Flu fears is the type of challenge that could send...ding to Dr. David Benton, business growth expert a...stem – The Rfactor Intensive . “Fea...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...ers in Australia have been accused of using privat...le not passing on cost increases to hospitals // ....gain asked Federal Health Minister Tony Abbott las...ouble the inflation rate. The nation's biggest...
...apy is a very old way of treating psychological di...ty years ago // . There has been lot of questi...that made the psychologist to view problems of the...idely accepted by many psychologists. In t...
...rvous system gets affected by rabies which is tran.... Immediate medical attention // is required for ... or raccoon which is rabid. If bite from an animal...stantly. The bite injury should be washed th...
... 9-year-old Chinese boy against a local health age...in favor of the health concern // , much to the di...rs. The boy is said to have contracted the v...d the infected blood product. Both parents have be...
...onals in New Zealand are seeking legal protection ...n the country, when they would be compelled to wor...nal health and safety (OSH) regulations in force i...there is an acute shortage of medical professional...
...developer Peplin has said that it would speed up t...cer cream since it was able to get an amount of $1...purpose. The company based in Queensland, Au...scription to your pharmacist, you’ll get it filled...
Other Medicine News:Health News:Australian Health funds stand accused 2Health News:Boy Refused Compensation For HIV Infection Following Hospital Admission 2
...ple technologies to bring new automated parameters...on of RNA allows for fully-automated, random-acces...f nucleated red blood cells ensures accurate white...count. Two-dimensional Optical platelet counts wit...
...fferential analyzer based on the proven technology...ering 18 parameters and extensive QC and data mana...eeds to today's growing labs. The CELL-DYN 1800 is...dard physician office laboratory cabinets. The sys...
...s hematology needs in today's changing laboratory ...tube sampling, small sample requirements, and high...ematology lab. New challenges have made fast acces...implification of data interpretation necessary to ...
Precision Net
Medicine Products: